Literature DB >> 7615843

Clinicopathologic implications of Epstein-Barr virus related B cell lymphoma in immunocompromised patients.

J A Thomas1, D H Crawford, M Burke.   

Abstract

Entities:  

Mesh：

Year:  1995        PMID： 7615843      PMCID： PMC502541          DOI： 10.1136/jcp.48.4.287

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN： 0021-9746            Impact factor:   3.411


× No keyword cloud information.
  9 in total

1.  The changing pattern of posttransplant malignancies.

Authors:  I Penn
Journal:  Transplant Proc       Date:  1991-02       Impact factor: 1.066

2.  Immunohistology of Epstein-Barr virus-associated antigens in B cell disorders from immunocompromised individuals.

Authors:  J A Thomas; N A Hotchin; M J Allday; P Amlot; M Rose; M Yacoub; D H Crawford
Journal:  Transplantation       Date:  1990-05       Impact factor: 4.939

Review 3.  Epstein-Barr virus, immunodeficiency, and B cell lymphoproliferation.

Authors:  D W Hanto; G Frizzera; K J Gajl-Peczalska; R L Simmons
Journal:  Transplantation       Date:  1985-05       Impact factor: 4.939

4.  Posttransplant lymphoproliferative disease in thoracic organ transplant patients: ten years of cyclosporine-based immunosuppression.

Authors:  J M Armitage; R L Kormos; R S Stuart; F J Fricker; B P Griffith; M Nalesnik; R L Hardesty; J S Dummer
Journal:  J Heart Lung Transplant       Date:  1991 Nov-Dec       Impact factor: 10.247

5.  Epstein-Barr virus-associated syndromes in immunosuppressed liver transplant recipients. Clinical profile and recognition on routine allograft biopsy.

Authors:  P S Randhawa; R S Markin; T E Starzl; A J Demetris
Journal:  Am J Surg Pathol       Date:  1990-06       Impact factor: 6.394

6.  The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression.

Authors:  M A Nalesnik; R Jaffe; T E Starzl; A J Demetris; K Porter; J A Burnham; L Makowka; M Ho; J Locker
Journal:  Am J Pathol       Date:  1988-10       Impact factor: 4.307

7.  Epstein-Barr virus--determined clonality in posttransplant lymphoproliferative disease.

Authors:  D F Patton; C W Wilkowski; C A Hanson; R Shapiro; K J Gajl-Peczalska; A H Filipovich; K L McClain
Journal:  Transplantation       Date:  1990-06       Impact factor: 4.939

8.  Molecular genetic analysis of lymphoid tumors arising after organ transplantation.

Authors:  J Locker; M Nalesnik
Journal:  Am J Pathol       Date:  1989-12       Impact factor: 4.307

9.  Evidence for restricted Epstein-Barr virus latent gene expression and anti-EBNA antibody response in solid organ transplant recipients with posttransplant lymphoproliferative disorders.

Authors:  H Cen; P A Williams; H P McWilliams; M C Breinig; M Ho; J L McKnight
Journal:  Blood       Date:  1993-03-01       Impact factor: 22.113
  9 in total
  6 in total

Review 1.  Primary vitreoretinal lymphoma: a report from an International Primary Central Nervous System Lymphoma Collaborative Group symposium.

Authors:  Chi-Chao Chan; James L Rubenstein; Sarah E Coupland; Janet L Davis; J William Harbour; Patrick B Johnston; Nathalie Cassoux; Valerie Touitou; Justine R Smith; Tracy T Batchelor; Jose S Pulido
Journal:  Oncologist       Date:  2011-11-01

Review 2.  Role of donor versus recipient type Epstein-Barr virus in post-transplant lymphoproliferative disorders.

Authors:  T Haque; D H Crawford
Journal:  Springer Semin Immunopathol       Date:  1998

3.  18F-FDG PET/CT for the Diagnosis of Malignant and Infectious Complications After Solid Organ Transplantation.

Authors:  Nastassja Muller; Romain Kessler; Sophie Caillard; Eric Epailly; Fabrice Hubelé; Céline Heimburger; Izzie-Jacques Namer; Raoul Herbrecht; Cyrille Blondet; Alessio Imperiale
Journal:  Nucl Med Mol Imaging       Date:  2016-11-28

4.  In vitro cytokine production and growth inhibition of lymphoblastoid cell lines by CD4+ T cells from Epstein-Barr virus (EBV) seropositive donors.

Authors:  A D Wilson; J C Hopkins; A J Morgan
Journal:  Clin Exp Immunol       Date:  2001-10       Impact factor: 4.330

Review 5.  Insights into the biology of primary central nervous system lymphoma.

Authors:  Maciej M Mrugala; James L Rubenstein; Maurilio Ponzoni; Tracy T Batchelor
Journal:  Curr Oncol Rep       Date:  2009-01       Impact factor: 5.075

Review 6.  Intraocular lymphoma: a clinical perspective.

Authors:  J L Davis
Journal:  Eye (Lond)       Date:  2012-11-30       Impact factor: 3.775
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.